A detailed history of First National Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First National Corp holds 11,145 shares of ABT stock, worth $1.31 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
11,145
Previous 12,209 8.71%
Holding current value
$1.31 Million
Previous $1.27 Million 0.16%
% of portfolio
0.28%
Previous 0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$100.07 - $118.13 $106,474 - $125,690
-1,064 Reduced 8.71%
11,145 $1.27 Million
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $53,789 - $60,042
534 Added 4.57%
12,209 $1.27 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $1,533 - $1,876
17 Added 0.15%
11,675 $1.29 Million
Q2 2023

Jul 31, 2023

BUY
$100.78 - $112.29 $2,015 - $2,245
20 Added 0.17%
11,658 $1.27 Million
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $28,898 - $33,902
-304 Reduced 2.55%
11,638 $0
Q3 2022

Oct 24, 2022

SELL
$96.76 - $112.03 $1,548 - $1,792
-16 Reduced 0.13%
11,942 $1.16 Million
Q2 2022

Jul 18, 2022

BUY
$102.07 - $123.37 $11,635 - $14,064
114 Added 0.96%
11,958 $1.3 Million
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $2,850 - $3,476
25 Added 0.21%
11,844 $1.4 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $38,847 - $42,976
333 Added 2.9%
11,819 $1.4 Million
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $2,856 - $3,362
27 Added 0.24%
11,486 $1.05 Million
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $8,163 - $9,617
75 Added 0.66%
11,459 $1.37 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $10,710 - $11,670
-102 Reduced 0.89%
11,384 $1.25 Million
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $22,453 - $24,996
-286 Reduced 2.43%
11,486 $998,000
Q2 2019

Jul 30, 2019

SELL
$72.88 - $85.0 $7,288 - $8,500
-100 Reduced 0.84%
11,772 $990,000
Q4 2018

Jun 12, 2019

BUY
$65.56 - $74.27 $778,328 - $881,733
11,872 New
11,872 $859,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First National Corp Portfolio

Follow First National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.